Sort   by:  
 Page size 
UnknownPotential for Tight Junction Protein-Directed Drug Development Using Claudin Binders and Angubindin-1.
Not available
S-EPMC6719960 | biostudies-literature
UnknownComparison of Product Features and Clinical Trial Designs for the DTx Products with the Indication of Insomnia Authorized by Regulatory Authorities.
Not available
S-EPMC11530488 | biostudies-literature
UnknownOverview of the Japanese Rapid Introduction Premium as a drug pricing framework to enhance patient access to innovative drugs.
Not available
S-EPMC12777408 | biostudies-literature
UnknownEngineered membrane protein antigens successfully induce antibodies against extracellular regions of claudin-5.
Not available
S-EPMC5976803 | biostudies-literature
UnknownMonoclonal antibodies against extracellular domains of claudin-1 block hepatitis C virus infection in a mouse model.
Not available
S-EPMC4403477 | biostudies-literature
UnknownIdentification of claudin-4 binder that attenuates tight junction barrier function by TR-FRET-based screening assay.
Not available
S-EPMC5674027 | biostudies-literature
Sort   by:  
 Page size